TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -1 | 7 | 2 | 23 | 0 | 0 | 8 |
| S | %wins | 100 | 0 | 0 | 0 | 25 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/7/19 20:35 | 1/7/19 | IMDZ | Immune Design Corp. | DE | Health | Drug | Pharmaceutical Preparations | Ter Meulen Jan Henrik | WA | O | Chief Sc | S.d | -5 | 1.59 | 0 | -3 | -4 | 84 | D | ||||||||||||||
1/8/18 20:19 | 1/5/18 | IMDZ | Immune Design Corp. | DE | Health | Drug | Pharmaceutical Preparations | Ter Meulen Jan Henrik | WA | O | Chief Sc | S.d | -8 | 4.17 | 0 | -2 | -5 | 39 | D | ||||||||||||||
1/6/17 21:36 | 1/4/17 | IMDZ | Immune Design Corp. | DE | Health | Drug | Pharmaceutical Preparations | Ter Meulen Jan Henrik | WA | O | Chief Sc | S.d | -5 | 5.35 | 1 | -1 | -4 | 23 | D | -82 | -69 | -34 | -37 | -32 | -24 | -21 | -4 | -1 | 7 | 2 | 23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |